Overview

Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to see if the drug ezetimibe is a potential treatment for Nonalcoholic Steatohepatitis(NASH).
Phase:
Phase 2
Details
Lead Sponsor:
University of California, San Diego
Treatments:
Ezetimibe